| NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma AP Rapoport, EA Stadtmauer, GK Binder-Scholl, O Goloubeva, DT Vogl, ... Nature medicine 21 (8), 914-921, 2015 | 995 | 2015 |
| Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation JN Kochenderfer, ME Dudley, RO Carpenter, SH Kassim, JJ Rose, ... Blood, The Journal of the American Society of Hematology 122 (25), 4129-4139, 2013 | 709 | 2013 |
| Antibody to hepatitis C virus increases with time on hemodialysis. NM Hardy, S Sandroni, S Danielson, WJ Wilson Clinical nephrology 38 (1), 44-48, 1992 | 238 | 1992 |
| NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on … DL Porter, EP Alyea, JH Antin, M DeLima, E Estey, JHF Falkenburg, ... Biology of Blood and Marrow Transplantation 16 (11), 1467-1503, 2010 | 172 | 2010 |
| National Marrow Donor Program–sponsored multicenter, phase II trial of HLA-mismatched unrelated donor bone marrow transplantation using post-transplant cyclophosphamide BE Shaw, AM Jimenez-Jimenez, LJ Burns, BR Logan, F Khimani, ... Journal of Clinical Oncology 39 (18), 1971-1982, 2021 | 138 | 2021 |
| Proceedings from the National Cancer Institute’s second international workshop on the biology, prevention, and treatment of relapse after hematopoietic stem cell … M de Lima, DL Porter, M Battiwalla, MR Bishop, SA Giralt, NM Hardy, ... Biology of Blood and Marrow Transplantation 20 (1), 4-13, 2014 | 120 | 2014 |
| Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation MR Bishop, RM Dean, SM Steinberg, J Odom, SZ Pavletic, C Chow, ... Annals of oncology 19 (11), 1935-1940, 2008 | 88 | 2008 |
| Immune effector cell–associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes NG Holtzman, H Xie, S Bentzen, V Kesari, A Bukhari, F El Chaer, F Lutfi, ... Neuro-oncology 23 (1), 112-121, 2021 | 71 | 2021 |
| Association of GATA2 deficiency with severe primary Epstein-Barr virus (EBV) infection and EBV-associated cancers JI Cohen, L Dropulic, AP Hsu, CS Zerbe, T Krogmann, K Dowdell, ... Clinical Infectious Diseases 63 (1), 41-47, 2016 | 70 | 2016 |
| A phase II study of anti PD-1 antibody pembrolizumab, pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) AZ Badros, MH Kocoglu, N Ma, AP Rapoport, E Lederer, S Philip, P Lesho, ... Blood 126 (23), 506, 2015 | 70 | 2015 |
| Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation JA Yared, N Hardy, Z Singh, S Hajj, AZ Badros, M Kocoglu, S Yanovich, ... Bone marrow transplantation 51 (6), 850-852, 2016 | 61 | 2016 |
| Cytomorphologic features of salivary duct carcinoma on fine needle aspiration biopsy. A case report. S Dee, S Masood, JH Issacs Jr, NM Hardy Acta cytologica 37 (4), 539-542, 1993 | 43 | 1993 |
| Bioethical considerations of monoclonal B‐cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation NM Hardy, C Grady, R Pentz, M Stetler‐Stevenson, M Raffeld, ... British journal of haematology 139 (5), 824-831, 2007 | 38 | 2007 |
| Maximum surgical blood order schedule reduces hospital costs. NM Hardy, FH Bolen, CH Shatney The American surgeon 53 (4), 223-225, 1987 | 38 | 1987 |
| Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial ZD Crees, MP Rettig, RG Jayasinghe, K Stockerl-Goldstein, SM Larson, ... Nature medicine 29 (4), 869-879, 2023 | 34 | 2023 |
| Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation DH Fowler, ME Mossoba, SM Steinberg, DC Halverson, D Stroncek, ... Blood, The Journal of the American Society of Hematology 121 (15), 2864-2874, 2013 | 34 | 2013 |
| Rapid relapse of large B-cell lymphoma after CD19 directed CAR-T-cell therapy due to CD-19 antigen loss A Bukhari, F El Chaer, R Koka, Z Singh, E Hutnick, K Ruehle, ST Lee, ... American journal of hematology 94 (10), E273-E275, 2019 | 33 | 2019 |
| Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumab S Bathini, NG Holtzman, R Koka, Z Singh, E Wilding, Y Zou, K Ruehle, ... American journal of hematology 94 (8), E216-E219, 2019 | 33 | 2019 |
| Fine needle aspiration cytology of chondroid syringoma. Report of a case. S Masood, NM Hardy Acta cytologica 32 (4), 482-484, 1988 | 33 | 1988 |
| Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation NM Hardy, V Fellowes, JJ Rose, J Odom, S Pittaluga, SM Steinberg, ... Blood, The Journal of the American Society of Hematology 119 (12), 2956-2959, 2012 | 26 | 2012 |
